Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

10 US Approval Decisions To Look Out For In Q3

05 Jul 2021

• By Alexandra Shimmings

Related Content

US FDA Panel Nod For Teplizumab To Delay Type 1 Diabetes Comes On Strength Of Single Study

28 May 2021

ChemoCentryx’s Avacopan May Need Another Trial After Tepid Advisory Committee Vote

07 May 2021

How Sweden's Calliditas Built Up Its US Presence And Development Portfolio

02 Feb 2021

Pfizer Says JAKs Have Their Place Despite Xeljanz Safety Issues

04 Feb 2021

More Positive Data As Decision Day Looms For AstraZeneca Lupus Drug

02 Jun 2021

ChemoCentryx Soars On Phase III Avacopan Data In ANCA Vasculitis

26 Nov 2019

PFIC Space Hots Up With Albireo and Mirum Filings

09 Dec 2020

Atox ‘Remains On Track’ Despite ACCUTE Setback

10 Jul 2020

FDA Perturbed By Provention's Teplizumab Type 1 Diabetes Drug

09 Apr 2021

Merck & Co.’s Keytruda Stakes Another Adjuvant Flag, In RCC

08 Apr 2021

What Will JAK Inhibitor Safety Jitters Mean For Drug Sales?

07 Apr 2021

World-First Korean Nod For Hanmi's Neutropenia Contender Rolontis

23 Mar 2021

Inspection Delay Puts Back Hanmi/Spectrum’s Rolontis

28 Oct 2020

Merck Buys Peloton On Eve Of IPO, Expands Kidney Cancer Portfolio

22 May 2019

Related Companies

AstraZeneca PLC

GSK plc

Provention Bio, Inc.

MacroGenics, Inc.

Eli Lilly and Company

Albireo Pharma Inc.

ChemoCentryx, Inc.

Pfizer Inc.

Sanofi

Regeneron Pharmaceuticals, Inc.

Incyte Corporation

Sesen Bio, Inc.

Merck & Co., Inc.

Hikma Pharmaceuticals plc

Calliditas Therapeutics AB

Spectrum Pharmaceuticals, Inc.

Hanmi Pharmaceutical Co., Ltd.

Atox Bio

Additional Topics

Approvals Companies Regulation Research & Development Cancer Dermatology Immune Disorders Metabolic Disorders Inflammation BioPharmaceutical Renal Infectious Diseases

More from New Products

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.